These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9073383)

  • 1. Nonionic triblock copolymers facilitate delivery of exogenous proteins into the MHC class I and class II processing pathways.
    Ke Y; McGraw CL; Hunter RL; Kapp JA
    Cell Immunol; 1997 Mar; 176(2):113-21. PubMed ID: 9073383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
    Shen Z; Reznikoff G; Dranoff G; Rock KL
    J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1992 Feb; 148(4):1016-24. PubMed ID: 1737924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
    Grant EP; Rock KL
    J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
    Rock KL; Rothstein L; Fleischacker C; Gamble S
    J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo.
    Ghumman B; Bertram EM; Watts TH
    J Immunol; 1998 Oct; 161(7):3262-70. PubMed ID: 9759841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
    Rock KL; Rothstein L; Gamble S; Fleischacker C
    J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.
    Harding CV; France J; Song R; Farah JM; Chatterjee S; Iqbal M; Siman R
    J Immunol; 1995 Aug; 155(4):1767-75. PubMed ID: 7636233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak base amines can inhibit class I MHC-restricted antigen presentation.
    Michalek MT; Benacerraf B; Rock KL
    J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.